These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10390248)

  • 41. Multiple-dose pharmacokinetics of ceftazidime and its influence on fecal flora.
    Kemmerich B; Warns H; Lode H; Borner K; Koeppe P; Knothe H
    Antimicrob Agents Chemother; 1983 Sep; 24(3):333-8. PubMed ID: 6357074
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics of cefuroxime and ceftazidime in patients with acute renal failure treated by continuous arteriovenous haemodialysis.
    Davies SP; Lacey LF; Kox WJ; Brown EA
    Nephrol Dial Transplant; 1991; 6(12):971-6. PubMed ID: 1798597
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cefepime versus ceftazidime: considerations for empirical use in critically ill patients.
    Roberts JA; Webb SA; Lipman J
    Int J Antimicrob Agents; 2007 Feb; 29(2):117-28. PubMed ID: 17158033
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Population pharmacokinetics of ceftazidime in intensive care unit patients: influence of glomerular filtration rate, mechanical ventilation, and reason for admission.
    Georges B; Conil JM; Seguin T; Ruiz S; Minville V; Cougot P; Decun JF; Gonzalez H; Houin G; Fourcade O; Saivin S
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4483-9. PubMed ID: 19635962
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The pharmacokinetics and tissue penetration of ceftazidime and cefamandole in healthy volunteers.
    Wise ER; Armstrong GC; Brown RM; Andrews JM
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():277-82. PubMed ID: 19802998
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics of intravenous and oral levofloxacin in critically ill adults in a medical intensive care unit.
    Rebuck JA; Fish DN; Abraham E
    Pharmacotherapy; 2002 Oct; 22(10):1216-25. PubMed ID: 12389872
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Advancing age and acute infection influence the kinetics of ceftazidime.
    Ljungberg B; Nilsson-Ehle I
    Scand J Infect Dis; 1989; 21(3):327-32. PubMed ID: 2667099
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics of ceftazidime in elderly patients and young volunteers.
    Ljungberg B; Nilsson-Ehle I
    Scand J Infect Dis; 1984; 16(3):325-6. PubMed ID: 6387894
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Determine Optimal Dosing of Ceftazidime-Avibactam for the Treatment of Acute Pulmonary Exacerbations in Patients with Cystic Fibrosis.
    Bensman TJ; Wang J; Jayne J; Fukushima L; Rao AP; D'Argenio DZ; Beringer PM
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784670
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Single- and multiple-dose pharmacokinetics of ceftazidime in infected patients with varying degrees of renal function.
    Lin MS; Wang LS; Huang JD
    J Clin Pharmacol; 1989 Apr; 29(4):331-7. PubMed ID: 2656776
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multiple-dose pharmacokinetics of amikacin and ceftazidime in critically ill patients with septic multiple-organ failure during intermittent hemofiltration.
    Kinowski JM; de la Coussaye JE; Bressolle F; Fabre D; Saissi G; Bouvet O; Galtier M; Eledjam JJ
    Antimicrob Agents Chemother; 1993 Mar; 37(3):464-73. PubMed ID: 8460915
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Population Pharmacokinetics of Unbound Ceftolozane and Tazobactam in Critically Ill Patients without Renal Dysfunction.
    Sime FB; Lassig-Smith M; Starr T; Stuart J; Pandey S; Parker SL; Wallis SC; Lipman J; Roberts JA
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31358583
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The pharmacokinetics of ceftazidime in patients with impaired renal function and concurrent frusemide therapy.
    Walstad RA; Dahl K; Hellum KB; Thurmann-Nielsen E
    Eur J Clin Pharmacol; 1988; 35(3):273-9. PubMed ID: 3053209
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams.
    Gonçalves-Pereira J; Póvoa P
    Crit Care; 2011; 15(5):R206. PubMed ID: 21914174
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics and Pharmacodynamics of Extended-Infusion Cefepime in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Prospective, Open-Label Study.
    Philpott CD; Droege CA; Droege ME; Healy DP; Courter JD; Ernst NE; Harger NJ; Foertsch MJ; Winter JB; Carter KE; Van Fleet SL; Athota K; Mueller EW
    Pharmacotherapy; 2019 Nov; 39(11):1066-1076. PubMed ID: 31549737
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis.
    Angus BJ; Smith MD; Suputtamongkol Y; Mattie H; Walsh AL; Wuthiekanun V; Chaowagul W; White NJ
    Br J Clin Pharmacol; 2000 Aug; 50(2):184-91. PubMed ID: 10930972
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intermittent intraperitoneal ceftazidime dosing in end-stage renal disease.
    Dumler F; Gottschling L; Umstead G; Wilson JM
    ASAIO J; 1998; 44(5):M411-4. PubMed ID: 9804462
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.
    Isla A; Gascón AR; Maynar J; Arzuaga A; Toral D; Pedraz JL
    Clin Ther; 2005 May; 27(5):599-608. PubMed ID: 15978309
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetics of cefodizime following single doses of 0.5, 1.0, 2.0, and 3.0 grams administered intravenously to healthy volunteers.
    Lenfant B; Namour F; Logeais C; Coussediere D; Rivault O; Bryskier A; Surjus A
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2037-41. PubMed ID: 8540712
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics of ceftazidime in sheep and its penetration into tissue and peritoneal fluids.
    Rule R; Rubio M; Perelli MC
    Res Vet Sci; 1991 Nov; 51(3):233-8. PubMed ID: 1780573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.